国家药监局：全链条支持疫苗产业高质量发展

Core Viewpoint - The National Medical Products Administration (NMPA) emphasizes the importance of vaccine regulation and the need for enhanced oversight and quality assurance in the vaccine industry [1] Group 1: Regulatory Enhancements - The NMPA has been strengthening the vaccine regulatory system and capabilities in recent years [1] - There is an ongoing effort to increase the intensity of vaccine production and distribution oversight [1] Group 2: Strategic Importance of Vaccines - Vaccines are recognized for their strategic, public welfare, and sensitive nature, necessitating strict regulatory measures [1] - The meeting highlighted the need to implement the "four strictest" requirements to ensure compliance [1] Group 3: Industry Development - The NMPA is promoting the digital and intelligent transformation of the vaccine industry [1] - There is an exploration of innovative regulatory mechanisms and methods to enhance oversight [1] Group 4: Risk Management - The meeting underscored the importance of strengthening risk prediction and management to ensure vaccine safety [1] - A comprehensive approach is being taken to support the high-quality development of the vaccine industry [1]